Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $8.5550 (-7.66%) ($8.5550 - $8.5550) on Thu. Dec. 10, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.78% (three month average) | RSI | 38 | Latest Price | $8.5550(-7.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -3.7% a day on average for past five trading days. | Weekly Trend | AUTL declines -2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) ARKG(13%) BNDX(13%) LIT(13%) SKYY(13%) XBI(13%) | Factors Impacting AUTL price | AUTL will decline at least -2.39% in a week (0% probabilities). TBT(-9%) USO(-7%) UNG(-7%) VIXM(-6%) SHY(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.39% (StdDev 4.78%) | Hourly BBV | -0 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $10.41 | 5 Day Moving Average | $10.16(-15.8%) | 10 Day Moving Average | $10.13(-15.55%) | 20 Day Moving Average | $10.41(-17.82%) | To recent high | -40.1% | To recent low | 0% | Market Cap | $447m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |